Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6DGT

Selective PI3K beta inhibitor bound to PI3K delta

Summary for 6DGT
Entry DOI10.2210/pdb6dgt/pdb
DescriptorPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform, 4-[1-(5,8-difluoroquinolin-4-yl)-2-methyl-4-(4H-1,2,4-triazol-3-yl)-1H-benzimidazol-6-yl]-3-fluoropyridin-2-amine (3 entities in total)
Functional Keywordspi3k delta, p110, inhibitor, transferase-transferase inhibitor complex, transferase/transferase inhibitor
Biological sourceMus musculus (Mouse)
Total number of polymer chains1
Total formula weight108110.90
Authors
Somoza, J.,Villasenor, A.,McGrath, M. (deposition date: 2018-05-18, release date: 2018-08-01, Last modification date: 2024-03-13)
Primary citationChandrasekhar, J.,Dick, R.,Van Veldhuizen, J.,Koditek, D.,Lepist, E.I.,McGrath, M.E.,Patel, L.,Phillips, G.,Sedillo, K.,Somoza, J.R.,Therrien, J.,Till, N.A.,Treiberg, J.,Villasenor, A.G.,Zherebina, Y.,Perreault, S.
Atropisomerism by Design: Discovery of a Selective and Stable Phosphoinositide 3-Kinase (PI3K) beta Inhibitor.
J. Med. Chem., 61:6858-6868, 2018
Cited by
PubMed Abstract: Atropisomerism is a type of axial chirality in which enantiomers or diastereoisomers arise due to hindered rotation around a bond axis. In this manuscript, we report a case in which torsional scan studies guided the thoughtful creation of a restricted axis of rotation between two heteroaromatic systems of a phosphoinositide 3-kinase (PI3K) β inhibitor, generating a pair of atropisomeric compounds with significantly different pharmacological and pharmacokinetic profiles. Emblematic of these differences, the metabolism of inactive ( M)-28 is primarily due to the cytosolic enzyme aldehyde oxidase, while active ( P)-28 has lower affinity for aldehyde oxidase, resulting in substantially better metabolic stability. Additionally, we report torsional scan and experimental studies used to determine the barriers of rotation of this novel PI3Kβ inhibitor.
PubMed: 30015489
DOI: 10.1021/acs.jmedchem.8b00797
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.601 Å)
Structure validation

247536

PDB entries from 2026-01-14

PDB statisticsPDBj update infoContact PDBjnumon